Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity
- 1 November 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 56 (10) , 1315-1322
- https://doi.org/10.1016/s0006-2952(98)00205-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell lineBiochemical Pharmacology, 1998
- Effects of Uracil Incorporation, DNA Mismatches, and Abasic Sites on Cleavage and Religation Activities of Mammalian Topoisomerase IJournal of Biological Chemistry, 1997
- Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11Cancer Chemotherapy and Pharmacology, 1997
- The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996Critical Reviews in Oncology/Hematology, 1996
- Thymidylate synthase and drug resistanceEuropean Journal Of Cancer, 1995
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Single step LC method for determination of folypolyglutamate synthetase activity and separation of polyglutamatesChromatographia, 1993
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- A Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysisCytometry, 1983